Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Category: Diabetes

388-P: Keap1-Nrf2 Modulation and SLC7A11 Restoration—Bardoxolone Methyl as a Ferroptosis Inhibitor in Renal Tubular Epithelial Cells

July 1, 2025 by sugaradmin

Introduction and Objective: Ferroptosis of renal tubular epithelial cells (RTECs) is implicated in the pathogenesis of diabetic kidney disease (DKD). Bardoxolone methyl (BM), a synthetic triterpenoid with antioxidant and anti-inflammatory properties, has shown promise in clinical trials for preventing DKD-related renal decline but carries a risk of heart failure. Recent studies revealed that 2-deoxy-D-ribose (dRib) […]

Read More
DiabetesLeave a Comment on 388-P: Keap1-Nrf2 Modulation and SLC7A11 Restoration—Bardoxolone Methyl as a Ferroptosis Inhibitor in Renal Tubular Epithelial Cells

825-P: AI-Based Optimization of Patient Eligibility for Oral Insulin Treatment—A Post Hoc Analysis to Identify Responders

July 1, 2025 by sugaradmin

Introduction and Objective: In a Phase III, randomized, placebo-controlled, multi-center study in which T2DM patients were treated with oral insulin for 26 weeks, the primary endpoint defined as a decrement of 0.6% HbA1c by end of treatment was not met. A post-hoc analysis aimed to identify subpopulations with substantial clinical responses to treatment.Methods: Explainable AI […]

Read More
DiabetesLeave a Comment on 825-P: AI-Based Optimization of Patient Eligibility for Oral Insulin Treatment—A Post Hoc Analysis to Identify Responders

114-OR: The Mammalian Adipose Tissue Knowledge Portal (MATKP)—An Open-Access Web Resource Providing Data and Knowledge Related to Mammalian Adipose Tissue

July 1, 2025 by sugaradmin

Introduction and Objective: Diabetes and adipose research generate rich datasets whose accessibility and integration are often limited. To address this challenge, we created the Mammalian Adipose Tissue Knowledge Portal (MATKP; matkp.org), an open community portal for multi-species mammalian adipose biology. MATKP is accessible to diverse users and aggregates data for adipose tissues and cell types, […]

Read More
DiabetesLeave a Comment on 114-OR: The Mammalian Adipose Tissue Knowledge Portal (MATKP)—An Open-Access Web Resource Providing Data and Knowledge Related to Mammalian Adipose Tissue

928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)

July 1, 2025 by sugaradmin

Introduction and Objective: HCL is the preferred insulin delivery method for people with T1D, however mealtime carbohydrate counting limits benefit. Use of AI to implement automated insulin delivery (AID) algorithms, able to avoid mealtime interactions, could alleviate burden and broaden use. We tested the latest UVA AID neural network-based system (AIDANET) in FCL in a […]

Read More
DiabetesLeave a Comment on 928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)

535-P: Objectively and Subjectively Measured Physical Activity in Chinese Immigrants with Type 2 Diabetes in New York City

July 1, 2025 by sugaradmin

Introduction and Objective: There is a paucity of objectively measured physical activity (PA) data in underserved populations. We examined objectively measured and self-reported PA among Chinese immigrants with type 2 diabetes (T2D) in NYC.Methods: We analyzed baseline data from 60 participants. PA was measured by a wrist-worn ActiGraph GT9X accelerometer and the International Physical Activity […]

Read More
DiabetesLeave a Comment on 535-P: Objectively and Subjectively Measured Physical Activity in Chinese Immigrants with Type 2 Diabetes in New York City

927-P: Unlocking the Predictors of Improved Time in Range for Users of Automated Insulin Delivery Systems during Ramadan Fasting—Findings from the Hybrid-Ram Randomized Controlled Trial

June 30, 2025 by sugaradmin

Introduction and Objective: Automated insulin delivery (AID) systems adjust insulin delivery based on real-time glucose readings, offering potential advantages over open-loop insulin delivery (OLID). Ramadan fasting presents unique challenge for individuals with type 1 diabetes (T1D) due to significant fluctuations in glucose levels. This study aimed to identify the predictor factors associated with achieving better […]

Read More
DiabetesLeave a Comment on 927-P: Unlocking the Predictors of Improved Time in Range for Users of Automated Insulin Delivery Systems during Ramadan Fasting—Findings from the Hybrid-Ram Randomized Controlled Trial

1429-P: Planetary Health Diet—Associations with Cardiovascular Disease and Type 2 Diabetes Risks, and Long-Term Weight Change in Women with a History of Gestational Diabetes

June 30, 2025 by sugaradmin

Introduction and Objective: The Planetary Health Diet (PHD), introduced in 2019 by the EAT-Lancet Commission, promotes chronic disease prevention and environmental sustainability. However, evidence on PHD adherence and its association with type 2 diabetes (T2D), cardiovascular disease (CVD), and weight gain is scarce, especially among women with a history of gestational diabetes mellitus (GDM).Methods: We […]

Read More
DiabetesLeave a Comment on 1429-P: Planetary Health Diet—Associations with Cardiovascular Disease and Type 2 Diabetes Risks, and Long-Term Weight Change in Women with a History of Gestational Diabetes

926-P: Automated Insulin Delivery vs. Open-Loop Insulin Delivery during Ramadan in Patients with Type 1 Diabetes in Saudi Arabia—The Hybrid-Ram Randomized Controlled Trial

June 30, 2025 by sugaradmin

Introduction and Objective: Automated insulin delivery (AID) systems, adjusting insulin based on real-time glucose readings, may offer advantages over open-loop insulin delivery (OLID), especially during Ramadan fasting, which poses challenges for individuals with type 1 diabetes (T1D).Methods: This dual-center, open-label, randomized controlled trial compared AID systems (Medtronic MiniMed 780G [M780] and Tandem T-slim Control IQ […]

Read More
DiabetesLeave a Comment on 926-P: Automated Insulin Delivery vs. Open-Loop Insulin Delivery during Ramadan in Patients with Type 1 Diabetes in Saudi Arabia—The Hybrid-Ram Randomized Controlled Trial

1659-P: Oxytocin Is Robustly Expressed throughout the Small Intestine in Individuals with and without Type 2 Diabetes and Serum Neurophysin I Levels Are Reduced after Roux-en-y Gastric Bypass

June 30, 2025 by sugaradmin

Introduction and Objective: Oxytocin has been proposed to have anorexigenic effects and the gene is among the most upregulated in the small intestine after Roux-en-Y gastric bypass (RYGB) surgery. We evaluated oxytocin and oxytocin receptor gene expression along the intestinal tract in individuals with and without type 2 diabetes, and assessed circulating concentrations of the […]

Read More
DiabetesLeave a Comment on 1659-P: Oxytocin Is Robustly Expressed throughout the Small Intestine in Individuals with and without Type 2 Diabetes and Serum Neurophysin I Levels Are Reduced after Roux-en-y Gastric Bypass

925-P: Real-World Outcomes of the Integration of Omnipod 5 Insulin Pump and Freestyle Libre 2 plus Continuous Glucose Monitoring in Adults with Type 1 Diabetes

June 30, 2025 by sugaradmin

Introduction and Objective: Hybrid closed-loop (HCL) therapy has revolutionized the care for people living with type 1 diabetes (pwT1D). The integration of different technology devices evolves rapidly providing individuals with more options and flexibility. We aimed to assess real-world outcomes of the new HCL system integrating the tubeless Omnipod 5 insulin pump with FreeStyle Libre […]

Read More
DiabetesLeave a Comment on 925-P: Real-World Outcomes of the Integration of Omnipod 5 Insulin Pump and Freestyle Libre 2 plus Continuous Glucose Monitoring in Adults with Type 1 Diabetes

Posts navigation

Older posts
Newer posts

Recent Posts

  • 90 to 120 Minutes a Week May Help You Live Longer
  • Experimental Pill Nearly Doubles Survival Rates
  • Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!
  • Anne Hathaway Says Early Onset Cataract Left Her ‘Legally Blind’
  • What BMI Gets Wrong About Obesity and What You Can Do About It

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness